Accuracy and usability of artificial intelligence chatbot generated chemotherapy protocols
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 22, 2024 Category: Cancer & Oncology Authors: Efe Cem Erdat Merih Yalciner Yuksel Urun Source Type: research
The causality between Type 2 diabetes and breast cancer: a bidirectional two-sample Mendelian randomization study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 19, 2024 Category: Cancer & Oncology Authors: Lihan Zhang Shuochuan Liu Guangxing Yue Hong Niu Mengjin Hu Yuling Zheng Jingwen Tang Source Type: research
Belzutifan: a novel therapeutic for the management of von Hippel –Lindau disease and beyond
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 19, 2024 Category: Cancer & Oncology Authors: Lauren Curry Maryam Soleimani Source Type: research
Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 19, 2024 Category: Cancer & Oncology Authors: Daniel Lin Ruoding Tan Christie Teigland Sairy Hernandez Seung Kim Karl M Kilgore Source Type: research
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 17, 2024 Category: Cancer & Oncology Authors: Muhammad Furqan Siddharth Karanth Ravi K Goyal Beilei Cai Julien Rombi Keith L Davis Nydia Caro Teddy Saliba Source Type: research
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 17, 2024 Category: Cancer & Oncology Authors: Yasuyuki Kawamoto Chigusa Morizane Yoshito Komatsu Shunsuke Kondo Makoto Ueno Satoshi Kobayashi Masayuki Furukawa Lingaku Lee Taroh Satoh Daisuke Sakai Masafumi Ikeda Hiroshi Imaoka Arisa Miura Yutaka Hatanaka Isao Yokota Yoshiaki Nakamura Takayuki Yoshin Source Type: research
Cost –effectiveness analysis 3L of axicabtagene ciloleucel vs tisagenlecleucel and lisocabtagene maraleucel in Japan
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 10, 2024 Category: Cancer & Oncology Authors: Saaya Tsutsu é Shinichi Makita Hiroya Asou Hiroyuki Matsuda Reiko Yamaura Todd D Taylor Source Type: research
Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 10, 2024 Category: Cancer & Oncology Authors: Amin Haiderali Min Huang Wilbur Pan Katherine G Akers Dylan Maciel Andrew M Frederickson Source Type: research
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 9, 2024 Category: Cancer & Oncology Authors: Valentina Guarneri Jos é Luís Passos Coelho Francois P Duhoux Daniel Egle Jos é Ángel García-Sáenz Fr édérique Penault-Llorca Katri Selander Hans Wildiers Khalil Zaman Petra Laeis Markus Lucerna Jean-Yves Pierga Source Type: research
Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases: a retrospective study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 9, 2024 Category: Cancer & Oncology Authors: Shuangqing Lu Xiaokang Guo Zhengqiang Yang Yulan Sun Jiling Niu Xuquan Jing Hui Zhu Source Type: research
The impact of myelosuppression on quality of life of patients treated with chemotherapy
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 8, 2024 Category: Cancer & Oncology Authors: Jeffrey Crawford Dana Herndon Katerina Gmitter Jared Weiss Source Type: research
Real-world evidence in the reassessment of oncology therapies: payer perceptions from five countries
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 4, 2024 Category: Cancer & Oncology Authors: Murtuza Bharmal Ioannis Katsoulis Jane Chang Alex Graham Apostolina Stavropoulou Priti Jhingran Chris L Pashos Source Type: research
Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 4, 2024 Category: Cancer & Oncology Authors: Yonggang Li Zhe Xu Yuanyuan Li Tianjun Jiang Fanping Meng Junliang Fu Lei Huang Fengchao Wang Xia Wang Fusheng Wang Source Type: research
Patient engagement in designing and publishing research in prostate cancer: a scoping review
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - April 4, 2024 Category: Cancer & Oncology Authors: Linda Sutton Matthew Labriola Thomas Bognanno Shelby Moneer Jennifer Ghith Gustavo Rodriguez Latorya Moore Obaro Evuarherhe Alicia K. Morgans Source Type: research
Plain language summary of the TRANSFORM study primary analysis results: lisocabtagene maraleucel as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - March 28, 2024 Category: Cancer & Oncology Authors: Jeremy S Abramson Scott R Solomon Jon Arnason Patrick B Johnston Bertram Glass Veronika Bachanova Sami Ibrahimi Stephan Mielke Pim Mutsaers Francisco Hernandez-Ilizaliturri Koji Izutsu Franck Morschhauser Matthew Lunning Alessandro Crotta Sandrine Monthea Source Type: research
